Provided by Tiger Trade Technology Pte. Ltd.

Vanguard Health Care ETF

316.08
-3.7100-1.16%
Post-market: 318.092.01+0.64%18:42 EDT
Volume:231.16K
Turnover:73.56M
Market Cap:19.02B
PE:34.31
High:320.01
Open:319.37
Low:316.08
Close:319.79
52wk High:330.75
52wk Low:260.42
Shares:60.18M
Float Shares:60.18M
Volume Ratio:1.38
T/O Rate:0.38%
Dividend:4.62
Dividend Rate:1.46%
EPS(TTM):9.21
EPS(LYR):41.51
ROE:3.75%
ROA:0.89%
PB:0.96
PE(LYR):7.61

Loading ...

Eli Lilly Says Foundayo Drug Helped Patients Lose Weight in Phase 3 Trial

Dow Jones
·
16 mins ago

Eli Lilly’s Foundayo shows cardiovascular safety in type 2 diabetes study

TIPRANKS
·
53 mins ago

Lilly's Oral Glp-1, Foundayo (Orforglipron), Demonstrated Cardiovascular Safety Alongside Sustained A1c Reduction and Weight Loss in Its Largest and Longest Type 2 Diabetes Study

THOMSON REUTERS
·
58 mins ago

Eli Lilly - Achieve-4: Foundayo Shows 16% Lower Mace-4 and 23% Lower Mace-3 Risk vs Insulin Glargine

THOMSON REUTERS
·
58 mins ago

Eli Lilly - Foundayo Shows Smaller Egrf Reduction and Greater Albuminuria Reduction vs Insulin Glargine

THOMSON REUTERS
·
58 mins ago

Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
2 hours ago

Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
2 hours ago

Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements

GlobeNewswire
·
2 hours ago

Merck, 3M Share Losses Contribute to Dow's 286-Point Drop

Dow Jones
·
3 hours ago

Judge Denies In Part UnitedHealth's Motion to Dismiss CalPERS Suit

MT Newswires Live
·
4 hours ago

Judge Denies in Part UnitedHealth's Motion to Dismiss CalPERS Suit

MT Newswires Live
·
5 hours ago

Dow Drops 150 Points on Losses for Shares of Sherwin-Williams Co., Merck

Dow Jones
·
5 hours ago

Exchange-Traded Funds Higher, US Equities Mixed After Midday

MT Newswires Live
·
5 hours ago

Sector Update: Healthcare

MT Newswires Live
·
5 hours ago

Lilly’s Clazakizumab Trial Pushes Cardiovascular Inflammation Strategy Forward

TIPRANKS
·
6 hours ago

AbbVie Wraps Key Early Trial on ABBV-722 Drug Interaction, Supporting Pipeline Confidence

TIPRANKS
·
6 hours ago

AbbVie’s Bretisilocin Study Completion Signals Quiet Progress in Early-Stage Pipeline

TIPRANKS
·
6 hours ago

MLP Sağlık Hizmetleri Secures $10M Directors and Officers Insurance Coverage

TIPRANKS
·
Yesterday

Spyre Gains After Merck's Drug Succeeds in Skin Disease Trial

Reuters
·
Yesterday

Eli Lilly Reports 'Positive' Results From EloraTZP Trial

MT Newswires Live
·
Yesterday